| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |